ArticleJournal of personalized medicine2021
The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine.
Ariel Kantor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it